Mary Kay James is an expert in corporate venture investing with a focus on agriculture and nutrition & health. She works closely with the DuPont Pioneer business looking for new opportunities in precision agriculture, seed trait enhancement, and genetic transformation.

Her responsibilities also span the nutrition & health sector where she proactively identifies strategic opportunities in food, beverage, and supplements that address digestive, metabolic and cardiovascular health, as well as specialty food protection ingredients. Mary Kay is very active in the venture capital community and is currently the chairperson of the National Venture Capital Association's (NVCA) Corporate Ventures Group (CVG).

Fund's investment verticals: agriculture, transportation, construction, clean-tech, electronic materials, nutrition and health, safety technology, performance materials and coatings, and color technologies.